Press releases

Genoskin, a biotechnology company developing ready-to-use human skin biopsies for ex vivo clinical testing, announces today the launch of its newest offering, NativeSkin^® access, a ready-to-use standardized skin model.

Genemarkers and Genoskin are pleased to announce they have formed a partnership to provide exceptional value and service to researchers in the fields of cosmetic and pharmaceutical topical solutions. The Companies are currently performing collaborative work to understand how cannabidiol (CBD) acts in the skin.

Genoskin appoints Eric Merle as first chief commercial officer   Salem, MA. – January 4, 2019 – Genoskin, an innovative provider of ex vivo clinical testing skin models and solutions, announced today the addition of Eric Merle as the company’s first chief commercial officer. The new position will see him take responsibility for all regions in which Genoskin operates. Eric has

Read more

“Genoskin is the first biotechnology company in the area to obtain the ISO9001:2015 certification” says Mr Bonzom. “This confirms their position as a trustworthy preclinical research partner for customers developing new drugs and products that need to be tested on human skin.”